AvalehtGEHC • NASDAQ
add
GE HealthCare Technologies Inc
71,62 $
Pärast sulgemist:(0,00%)0,00
71,62 $
Suletud: 6. juuni, 16:58:52 GMT −4 · USD · NASDAQ · Välistus
Viimane sulgemishind
71,55 $
Tänane vahemik
70,88 $ - 72,45 $
Aasta vahemik
57,65 $ - 94,80 $
Turuväärtus
32,79 mld USD
Keskmine maht
4,67 mln
P/E suhe
15,06
Dividendimäär
0,20%
Põhibörs
NASDAQ
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Käive | 4,78 mld | 2,73% |
Põhitegevusega seonduv kulu | 1,31 mld | 3,90% |
Puhastulu | 564,00 mln | 50,80% |
Puhaskasumimarginaal | 11,81 | 46,89% |
Puhaskasum aktsia kohta | 1,01 | 12,22% |
EBITDA | 842,00 mln | 6,31% |
Tõhus maksumäär | 15,03% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 2,45 mld | −3,80% |
Kogu vara | 33,59 mld | 4,28% |
Kõik kohustused | 24,17 mld | −1,79% |
Kogu omakapital | 9,42 mld | — |
Emiteeritud aktsiate arv | 457,88 mln | — |
Hinna ja väärtuse suhe P/B | 3,57 | — |
Varade tasuvus | 5,29% | — |
Kapitali tasuvus | 9,64% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Puhastulu | 564,00 mln | 50,80% |
Põhitegevuse rahakäive | 250,00 mln | −40,33% |
Investeeringute raha | −407,00 mln | −116,49% |
Finantseerimise raha | −286,00 mln | −86,93% |
Raha ja raha ekvivalentide muutus | −417,00 mln | −806,78% |
Tasuta rahavoog | 30,00 mln | −90,57% |
Teave
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Tegevjuht
Asutatud
1994
Veebisait
Töötajate arv
53 000